News Medical on MSN
CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich's ataxia
The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for ...
Tiffany Fransen, diagnosed with Friedreich's ataxia, faces challenges from this rare disease. The genetic disorder affects ...
Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...
Drivers over the age of 70 will have to have their vision checked every three years under plans to reform driving laws ...
Detailed price information for Rakovina Therapeutics Inc (RKV-X) from The Globe and Mail including charting and trades.
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
According to INSIDE researchers, the non-invasive system now supports higher level of continuous, multi-dimensional control— ...
If you're considering a vitamin B12 supplement because of certain dietary restrictions, medical conditions or your age, this ...
Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU. Skyclarys ...
Abstract: Cerebellar ataxia is the poorly coordinated movement that results from injury or disease affecting the cerebellum. The diagnosis and assessment of ataxia are significantly challenging due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results